Related Experiment Video
Updated: Aug 13, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without
Huazhen Chen1, Alessandro Spirito1, Samantha Sartori1
1The Zena and Michael A. Wiener Cardiovascular institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
Insights
Complex percutaneous coronary intervention (CPCI) increases risks for major adverse cardiac events and bleeding in patients with and without chronic kidney disease (CKD). CPCI specifically predicted mortality in CKD patients.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Patients with chronic kidney disease (CKD) face elevated risks of ischemic and bleeding complications post-percutaneous coronary intervention (PCI).
- Complex PCI (CPCI) is known to increase ischemic complication rates.
- The combined impact of CPCI and CKD on adverse events remains unclear.
Purpose of the Study:
- To investigate whether complex PCI (CPCI) confers an additional risk of adverse cardiovascular events in patients with chronic kidney disease (CKD).
- To compare the outcomes of CPCI versus standard PCI in patients stratified by CKD status.
Main Methods:
- A retrospective analysis of 15,071 patients undergoing PCI between 2012 and 2019.
- Patients were categorized based on CKD status and whether they underwent CPCI.
- Primary outcome was major adverse cardiac events (MACE) at 1-year, including all-cause death, myocardial infarction (MI), and target-vessel revascularization (TVR). Major bleeding was a secondary outcome.
Main Results:
- Complex PCI (CPCI) was associated with a significantly higher risk of MACE in both CKD and non-CKD patients.
- CPCI increased the risk of death, MI, and TVR in CKD patients, and MI and TVR in non-CKD patients.
- Major bleeding risk also increased with CPCI in both CKD and non-CKD groups, though the association was stronger in CKD patients.
Conclusions:
- Complex PCI (CPCI) is linked to increased risks of MACE and major bleeding, regardless of chronic kidney disease (CKD) status.
- CPCI specifically emerged as a predictor of mortality solely in patients with CKD.
Background:
Patients with chronic kidney disease (CKD) are at higher risk of ischemic and bleeding events after percutaneous coronary intervention (PCI). Complex PCI (CPCI) is associated with higher rates of ischemic complications. Whether CPCI confers an additive risk of adverse events in CKD patients is unclear.
Methods:
Patients who underwent PCI at a single tertiary-care-center between 2012 and 2019 were stratified by CKD status and CPCI. The primary outcome was major adverse cardiac events (MACE), a composite of all-cause death, myocardial infarction (MI), and target-vessel revascularization (TVR) at 1-year follow-up. Secondary outcomes included the individual components of the primary outcome and major bleeding.
Results:
Out of 15,071 patients, 4537 (30.1%) had CKD and 10,534 (69.9%) had no CKD. Patients undergoing CPCI were 1151 (25.4%) and 2983 (28.3%) in the two cohorts, respectively. At one year, CPCI compared with no CPCI was associated with higher risk of MACE in both CKD (Adj. HR 1.72, 95% confidence interval [CI] 1.45-2.06, p < 0.001) and no-CKD patients (Adj. hazard ratios [HR] 2.19, 95% CI 1.91-2.51, p < 0.001; p of interaction 0.057), determined by an excess of death, MI and TVR in CKD patients and of TVR and MI only in no-CKD. CPCI was related with a consistent increase of major bleeding in the CKD (Adj. HR 1.49, 95% CI 1.18-1.87, p < 0.001) and no-CKD group (Adj. HR 1.23, 95% CI 0.98-1.54, p = 0.071, p of interaction 0.206).
Conclusion:
At 1-year follow-up, CPCI was associated with higher risk of MACE and major bleeding irrespective of concomitant CKD. CPCI predicted mortality in CKD patients only.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

